BCL2 and lymphoma: Studies using conditional gene targeting or inducible CRISPR platforms revealed that different malignant cells rely on the expression of distinct pro-survival BCL-2 proteins for their sustained survival, such as MCL-1 for MYC-driven lymphomas [135], even though their genes are not over-expressed owing to somatic copy number amplification or chromosomal translocation.